help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Journal of Clinical Endocrinology & Metabolism , doi:10.1210/jc.2008-0761
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by van der Crabben, S. N.
Right arrow Articles by Sauerwein, H. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by van der Crabben, S. N.
Right arrow Articles by Sauerwein, H. P.
Related Collections
Right arrow Diabetes and Insulin
Right arrow Metabolism
The Journal of Clinical Endocrinology & Metabolism Vol. 94, No. 2 463-468
Copyright © 2009 by The Endocrine Society

Early Endotoxemia Increases Peripheral and Hepatic Insulin Sensitivity in Healthy Humans

Saskia N. van der Crabben, Regje M. E. Blümer, Michiel E. Stegenga, Mariëtte T. Ackermans, Erik Endert, Michael W. T. Tanck, Mireille J. Serlie, Tom van der Poll and Hans P. Sauerwein

Department of Endocrinology and Metabolism (S.N.v.d.C., R.M.E.B., M.J.S., H.P.S.), Center for Experimental and Molecular Medicine (M.E.S., T.v.d.P.), Department of Clinical Chemistry, Laboratory of Endocrinology and Radiochemistry (M.T.A., E.E.), and Department of Clinical Epidemiology, Biostatistics, and Bioinformatics (M.W.T.T.), Academic Medical Center, 1100 DD Amsterdam, The Netherlands

Address all correspondence and requests for reprints to: S. N. van der Crabben, University Medical Center Utrecht (Wilhelmina Children’s Hospital), DBG Department of Clinical Genetics, KC. 04.084.2, Lundlaan 6, P.O. Box 85090, 3508 AB Utrecht, The Netherlands. E-mail: s.n.vandercrabben{at}umcutrecht.nl.

Context: Sepsis-induced hypoglycemia is a well known, but rare, event of unknown origin.

Objective: The aim of the study was to obtain insight into the mechanism of sepsis-induced hypoglycemia, focusing on glucose kinetics and insulin sensitivity measured with stable isotopes by using the model of human endotoxemia.

Design: Glucose metabolism was measured during two hyperinsulinemic [insulin levels of 100 pmol/liter (low-dose clamp) and 400 pmol/liter (medium-dose clamp)] euglycemic (5 mmol/liter) clamps on two occasions: without or with lipopolysaccharide (LPS).

Setting: The study was conducted at the Academic Medical Center, Metabolic and Clinical Research Unit (Amsterdam, The Netherlands).

Participants: Eighteen healthy male volunteers participated in the study.

Intervention: A hyperinsulinemic euglycemic (5 mmol/liter) clamp with LPS (two groups of six subjects; insulin infusion at rates of either 10 or 40 mU · m–2 · min–1) or without LPS (n = 6; both insulin infusions in same subjects).

Main Outcome Measure: We measured hepatic and peripheral insulin sensitivity.

Results: Hepatic insulin sensitivity, defined as a decrease in endogenous glucose production during hyperinsulinemia (100 pmol/liter), was higher in the LPS group compared to the control group (P = 0.010). Insulin-stimulated peripheral glucose uptake was higher in both clamps after LPS compared to the control setting (P = 0.006 and 0.010), despite a significant increase in the plasma concentrations of norepinephrine and cytokines in the LPS group during both clamps.

Conclusions: These data indicate that shortly (2 h) after administration of LPS, peripheral and hepatic insulin sensitivity increase. This may contribute to the hypoglycemia occurring in some patients with critical illness, especially in the setting of intensive insulin therapy.




This article has been cited by other articles:


Home page
Diabetes CareHome page
E. S. Moghissi, M. T. Korytkowski, M. DiNardo, D. Einhorn, R. Hellman, I. B. Hirsch, S. E. Inzucchi, F. Ismail-Beigi, M. S. Kirkman, and G. E. Umpierrez
American Association of Clinical Endocrinologists and American Diabetes Association Consensus Statement on Inpatient Glycemic Control
Diabetes Care, June 1, 2009; 32(6): 1119 - 1131.
[Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
A. Balasubramanyam
Intensive Glycemic Control in the Intensive Care Unit: Promises and Pitfalls
J. Clin. Endocrinol. Metab., February 1, 2009; 94(2): 416 - 417.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2009 by The Endocrine Society